Ureaplasma urealyticum and Ureaplasma parvum
Ureaplasma urealyticum; Ureaplasma parvum
General medical information for education only, not medical advice. Treatment considerations summarize published guidance at drug-class level; therapy is chosen by the treating clinician using susceptibility results, local resistance patterns and current guidelines.
Overview
Genitourinary bacteria without a cell wall that commonly colonize the urogenital tract.
Infections
U. urealyticum is associated with non-gonococcal urethritis in men; both species are linked to adverse pregnancy outcomes and to infection in immunocompromised patients.
Signs and symptoms
Urethral discharge and dysuria when symptomatic; frequently none.
Antibiotic and antimicrobial resistance
No cell wall: beta-lactams are ineffective.
Treatment considerations
Doxycycline or azithromycin when treatment is indicated; detection alone, without symptoms, often does not require treatment.

Sources
- CDC. Urethritis and cervicitis (STI Treatment Guidelines).
- CDC. Sexually Transmitted Infections Treatment Guidelines, 2021.
Sources accessed November 2026. Links open external sites that InnovexLab does not control.
Medical disclaimer
This page is general educational information summarized from published public-health and professional-society guidance. It is not medical advice, a diagnosis or a treatment recommendation, and reading it does not create a clinician–patient relationship with InnovexLab. Decisions about testing, diagnosis and treatment belong to the treating clinician, using the patient’s history and examination, laboratory and susceptibility results, local resistance patterns and current guidelines. Guidance changes over time; consult the original sources for the latest version. InnovexLab provides this information as is and does not warrant that it is complete or current.
Patients with questions about their health should contact their own healthcare provider. In an emergency, call 911.